BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Santen Pharmaceutical Co., Ltd. 

3-9-19 Shimo-Shinjo Higashi Yodogawa-ku

Osaka    533  Japan
Phone: 81-0-6-3217000 Fax: 81-0-6-3285082


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Santen Pharmaceutical And TRACON Pharmaceuticals, Inc. Announce Agreement For The Development And Commercialization Of TRC105 In Ophthalmology 3/4/2014 11:38:33 AM    More...
Santen Pharmaceutical Announces the Appointment of Naveed Shams, M.D., Ph.D. as the President and CEO 3/12/2013 9:39:52 AM    More...
Santen Pharmaceutical and Clearside Biomedical Enter Into Financing and Research Collaboration Agreements for Posterior Ocular Disease 1/31/2013 10:18:08 AM    More...
Eisai Company, Ltd. (ESALY.PK) and Santen Pharmaceutical Enter Into Option Agreement for New Ophthalmic Drugs 9/27/2012 4:14:34 PM    More...
Santen Pharmaceutical Nabs Japanese Co-Promotion Rights to Bayer HealthCare (BAY) and Regeneron Pharmaceuticals, Inc. (REGN)'s Eylea 5/8/2012 6:55:17 AM    More...
Santen Pharmaceutical to Buy Novagali Pharma for $136 Million 9/28/2011 6:50:17 AM    More...
Inspire Pharmaceuticals, Inc. (ISPH) Announces Launch of DIQUASTM by Santen Pharmaceutical in Japan 12/13/2010 8:45:16 AM    More...
Clinical Data, Inc. Licenses Adenosine A2A Agonist to Santen Pharmaceutical for Development of Ophthalmic Treatments 5/3/2010 9:30:50 AM    More...
Santen Pharmaceutical And Inspire Pharmaceuticals, Inc. (ISPH) Announce Approval of DIQUAS(TM) for Dry Eye Treatment in Japan 4/16/2010 11:42:28 AM    More...
Japan's Santen Pharmaceutical Licenses Glaucoma Drug to Merck & Co., Inc. (MRK) (JOBS) 4/15/2009 7:07:18 AM    More...
12